152 related articles for article (PubMed ID: 38213724)
1. Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions.
Dong M; Luo H; Liu R; Zhang J; Yang Z; Wang D; Wang Y; Chen J; Ou Y; Zhang Q; Wang X
J Cancer; 2024; 15(3):699-713. PubMed ID: 38213724
[No Abstract] [Full Text] [Related]
2. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair.
Kong Y; Xu C; Sun X; Sun H; Zhao X; He N; Ji K; Wang Q; Du L; Wang J; Zhang M; Liu Y; Wang Y; Liu Q
Cancer Biol Med; 2021 Dec; 19(8):1150-71. PubMed ID: 34846107
[TBL] [Abstract][Full Text] [Related]
3. Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons.
Park S; Choi C; Kim H; Shin YJ; Oh Y; Park W; Cho WK; Kim N
Breast Cancer Res Treat; 2024 Feb; 203(3):449-461. PubMed ID: 37902934
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors.
Mangoni M; Sottili M; Salvatore G; Meattini I; Desideri I; Greto D; Loi M; Becherini C; Garlatti P; Delli Paoli C; Dominici L; Gerini C; Scoccianti S; Bonomo P; Silvano A; Beltrami G; Campanacci D; Livi L
Radiat Res; 2018 Nov; 190(5):464-472. PubMed ID: 30067444
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1/CHK2 inhibitor AZD7762, Honokiol and Tunicamycin.
Liu B; Chen W; Li H; Li F; Jin X; Li Q
Radiat Environ Biophys; 2020 Nov; 59(4):723-732. PubMed ID: 32857208
[TBL] [Abstract][Full Text] [Related]
6. Berberine enhances the radiosensitivity of osteosarcoma by targeting Rad51 and epithelial-mesenchymal transition.
Wang D; Zhang KF; Du G; Wang J; Zhao J
J Cancer Res Ther; 2020; 16(2):215-221. PubMed ID: 32474504
[TBL] [Abstract][Full Text] [Related]
7. [Effect and Mechanism of Radiosensitization of Poly (ADP-Ribose) Polymerase Inhibitor n Lewis Cells and Xenografts].
Wang W; Duan B; Zeng L
Zhongguo Fei Ai Za Zhi; 2016 Jan; 19(1):16-23. PubMed ID: 26805733
[TBL] [Abstract][Full Text] [Related]
8. TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.
Lee Y; Sunada S; Hirakawa H; Fujimori A; Nickoloff JA; Okayasu R
Mol Cancer Ther; 2017 Jan; 16(1):16-24. PubMed ID: 28062703
[TBL] [Abstract][Full Text] [Related]
9. Long time persistence of residual 53BP1/γ-H2AX foci in human lymphocytes in relationship to apoptosis, chromatin condensation and biological dosimetry.
Marková E; Torudd J; Belyaev I
Int J Radiat Biol; 2011 Jul; 87(7):736-45. PubMed ID: 21718211
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiation.
Hirai T; Shirai H; Fujimori H; Okayasu R; Sasai K; Masutani M
Cancer Sci; 2012 Jun; 103(6):1045-50. PubMed ID: 22404155
[TBL] [Abstract][Full Text] [Related]
11. Combining Carbon-Ion Irradiation and PARP Inhibitor, Olaparib Efficiently Kills BRCA1-Mutated Triple-Negative Breast Cancer Cells.
Kawanishi M; Fujita M; Karasawa K
Breast Cancer (Auckl); 2022; 16():11782234221080553. PubMed ID: 35340889
[TBL] [Abstract][Full Text] [Related]
12. The combination of olaparib and camptothecin for effective radiosensitization.
Miura K; Sakata K; Someya M; Matsumoto Y; Matsumoto H; Takahashi A; Hareyama M
Radiat Oncol; 2012 Apr; 7():62. PubMed ID: 22524618
[TBL] [Abstract][Full Text] [Related]
13. Dual Inhibition of PARP and the Intra-S/G2 Cell Cycle Checkpoints Results in Highly Effective Radiosensitization of HPV-Positive HNSCC Cells.
Hintelmann K; Berenz T; Kriegs M; Christiansen S; Gatzemeier F; Struve N; Petersen C; Betz C; Rothkamm K; Oetting A; Rieckmann T
Front Oncol; 2021; 11():683688. PubMed ID: 34354944
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA
BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663
[TBL] [Abstract][Full Text] [Related]
15. JF-305, a pancreatic cancer cell line is highly sensitive to the PARP inhibitor olaparib.
Yang X; Ndawula C; Zhou H; Gong X; Jin J
Oncol Lett; 2015 Feb; 9(2):757-761. PubMed ID: 25621047
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy.
Johnson AM; Bennett PV; Sanidad KZ; Hoang A; Jardine JH; Keszenman DJ; Wilson PF
Front Oncol; 2021; 11():735940. PubMed ID: 34513712
[TBL] [Abstract][Full Text] [Related]
17. The PARP-1 inhibitor Olaparib suppresses BRCA1 protein levels, increases apoptosis and causes radiation hypersensitivity in BRCA1
Bourton EC; Ahorner PA; Plowman PN; Zahir SA; Al-Ali H; Parris CN
J Cancer; 2017; 8(19):4048-4056. PubMed ID: 29187880
[TBL] [Abstract][Full Text] [Related]
18. Combined inhibition of Wee1 and PARP1/2 for radiosensitization in pancreatic cancer.
Karnak D; Engelke CG; Parsels LA; Kausar T; Wei D; Robertson JR; Marsh KB; Davis MA; Zhao L; Maybaum J; Lawrence TS; Morgan MA
Clin Cancer Res; 2014 Oct; 20(19):5085-96. PubMed ID: 25117293
[TBL] [Abstract][Full Text] [Related]
19. Combined olaparib and oxaliplatin inhibits tumor proliferation and induces G2/M arrest and γ-H2AX foci formation in colorectal cancer.
Xu K; Chen Z; Cui Y; Qin C; He Y; Song X
Onco Targets Ther; 2015; 8():3047-54. PubMed ID: 26543375
[TBL] [Abstract][Full Text] [Related]
20. Long-term in vivo effects of cisplatin on gamma-H2AX foci signaling in peripheral lymphocytes of tumor patients after irradiation.
Sak A; Grehl S; Engelhard M; Wierlemann A; Kaelberlah HP; Erichsen P; Pöttgen C; Groneberg M; Stuschke M
Clin Cancer Res; 2009 Apr; 15(8):2927-34. PubMed ID: 19336520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
